Biomarkers – News and Features

Older people who follow a Mediterranean diet are at a lower risk of cognitive decline, reports a new study that highlights the biological mechanisms related to the impact of diet on cognitive health.

Suicidal behavior is driven by a mix of psychological, social and biological factors. New research has identified overactive inflammation and loss of critical protection mechanisms in the brain as potential contributors to suicide risk.

Shrinkage in the hippocampus area of the brain is associated with cognitive decline, even in people who don’t have amyloid plaques in the brain, reports new research.

Antimicrobial resistance (AMR) is threatening the effective treatment and prevention of a wide range of infections, with serious potential consequences for health and the economy. We spoke to Dr. Alaa Riezk, research associate at the Centre for Antimicrobial Optimisation (CAMO), Imperial College London, about the problem of usage and dosage of antimicrobials and AMR and how he and the team are working to address it.

This article looks at the technologies currently being developed that can help to identify patients with a higher risk of prostate cancer, ultimately reducing the number of unnecessary biopsies.

Cancer stem cells cause the aging of macrophages in mice with healthy immune systems, creating conditions for the formation of tumors.

An international team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer’s and Parkinson’s Diseases.

A model based on artificial intelligence is able to predict the therapy outcome in 80% of ovarian cancer patients. The tool, named IRON (Integrated Radiogenomics for Ovarian Neoadjuvant therapy), analyzes various patient clinical features.

A simple blood test that detects IgG antibody aggregates, a biomarker for multiple sclerosis, with 90% accuracy could enhance MS diagnostics.

New research has discovered that breast cancer cells expressing the Myc gene rely heavily on vitamin B5 to grow and survive, which could potentially be exploited as a therapeutic avenue.